MedTech Acquisition Co. (OTCMKTS:MTACU – Get Free Report) shares rose 19.5% during mid-day trading on Friday. The company traded as high as $11.35 and last traded at $11.35. Approximately 1,900 shares changed hands during trading, an increase of 225% from the average daily volume of 585 shares. The stock had previously closed at $9.50.
MedTech Acquisition Trading Up 19.5%
The company has a fifty day moving average price of $11.35 and a 200 day moving average price of $11.35.
MedTech Acquisition Company Profile
MedTech Acquisition Corporation is a special purpose acquisition company (SPAC) formed to identify and combine with a business in the medical technology, healthcare, or related life sciences sectors. Its publicly traded units are associated with the OTC Markets symbol MTACU.
Unlike an operating medical-device or healthcare company, MedTech Acquisition does not appear to have a portfolio of commercial products or ongoing service operations of its own. Its principal activity is evaluating potential merger, acquisition, or similar business-combination opportunities with a target company.
Publicly available information about MedTech Acquisition’s completed transactions, operating footprint, products, and leadership is limited.
Featured Articles
- Five stocks we like better than MedTech Acquisition
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for MedTech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedTech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
-etf-logo-1200x675.png){kind=logo}